Gain Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Gain Therapeutics

15/05/2023 13:00

* Gain Therapeutics Inc  GANX.OQ  reported a quarterly
adjusted
loss of 43 cents​​ per share for the quarter ended in March. The
mean expectation of three analysts for the quarter was for a
loss of 39 cents per share.
    * Revenue rose 22.2% to $55.00 thousand from a year ago;
analysts
expected zero. 
    * Gain Therapeutics Inc's reported EPS for the quarter was a
loss
of 43 cents​.
    * The mean earnings estimate of analysts had fallen by
about 7.3%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate 
    * Gain Therapeutics Inc shares had risen by 7.3% this
quarter and
gained 65.2% so far this year.
    * The company reported a quarterly loss of $5.14 million.
    * Wall Street's median 12-month price target for Gain
Therapeutics
Inc is $10.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
15 at 12:00 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.39          -0.43          Missed
 Dec. 31 2022      -0.38          -0.39          Missed
 Sep. 30 2022      -0.46          -0.38          Beat
 Jun. 30 2022      -0.31          -0.43          Missed